Número total de visitas
| Visualizaciones | |
|---|---|
| Epigenome-wide ... | 142 |
Visitas al mes
| junio 2025 | julio 2025 | agosto 2025 | septiembre 2025 | octubre 2025 | noviembre 2025 | diciembre 2025 | |
|---|---|---|---|---|---|---|---|
| Epigenome-wide ... | 9 | 11 | 0 | 4 | 7 | 3 | 9 |
Visitas al fichero
| Visualizaciones | |
|---|---|
| epigenome_wide_association_study_covid_19_severity_respiratory_failure_2021_taula1.pdf | 174 |
| epigenome_wide_association_study_covid_19_severity_respiratory_failure_2021_taula6.pdf | 152 |
| epigenome_wide_association_study_covid_19_severity_respiratory_failure_2021_figura3.pdf | 130 |
| epigenome_wide_association_study_covid_19_severity_respiratory_failure_2021_taula2.pdf | 126 |
| epigenome_wide_association_study_covid_19_severity_respiratory_failure_2021_figura6.pdf | 95 |
| epigenome_wide_association_study_covid_19_severity_respiratory_failure_2021.pdf | 68 |
| epigenome_wide_association_study_covid_19_severity_respiratory_failure_2021_taula4.pdf | 63 |
| epigenome_wide_association_study_covid_19_severity_respiratory_failure_2021_metodes.pdf | 59 |
| epigenome_wide_association_study_covid_19_severity_respiratory_failure_2021_figura2.pdf | 56 |
| epigenome_wide_association_study_covid_19_severity_respiratory_failure_2021_figura7.pdf | 39 |
Países con más visualizaciones
| Visualizaciones | |
|---|---|
| Estados Unidos | 50 |
| Singapur | 23 |
| España | 20 |
| China | 13 |
| Brasil | 7 |
| Alemania | 7 |
| Francia | 3 |
| Japón | 3 |
| Rusia | 2 |
| Vietnam | 2 |
Ciudades con más visualizaciones
| Visualizaciones | |
|---|---|
| Singapore | 17 |
| Barcelona | 12 |
| Ashburn | 10 |
| Beijing | 8 |
| Chicago | 8 |
| Chandler | 6 |
| Tokyo | 3 |
| Düsseldorf | 2 |
| Tarragona | 2 |
| Abaeté | 1 |



